Evidence map›Paper›PMID 38694517›Full record

Observational studyFrontiers in cellular and infection microbiology2024

Single nucleotide variants in the

Erik Chávez-Vélez, Francisco Álvarez-Nava, Alisson Torres-Vinueza, Thalía Balarezo-Díaz, Kathya Pilataxi, Camila Acosta-López, Ivonne Z Peña, Katherin Narváez

Open access · goldAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. The FunctionalInternational journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Erik Chávez-VélezCarrera de Biología, Facultad de Ciencias Biológicas, Universidad Central del Ecuador, Quito, Ecuador.
Francisco Álvarez-NavaCarrera de Biología, Facultad de Ciencias Biológicas, Universidad Central del Ecuador, Quito, Ecuador.
Alisson Torres-VinuezaCarrera de Biología, Facultad de Ciencias Biológicas, Universidad Central del Ecuador, Quito, Ecuador.
Thalía Balarezo-DíazCarrera de Biología, Facultad de Ciencias Biológicas, Universidad Central del Ecuador, Quito, Ecuador.
Kathya PilataxiCarrera de Biología, Facultad de Ciencias Biológicas, Universidad Central del Ecuador, Quito, Ecuador.
Camila Acosta-LópezCarrera de Biología, Facultad de Ciencias Biológicas, Universidad Central del Ecuador, Quito, Ecuador.
Ivonne Z PeñaUnidad de Cuidados Críticos de Adultos, Hospital Quito Sur del Instituto Ecuatoriano de Securidad Social, Quito, Ecuador.
Katherin NarváezUnidad de Cuidados Críticos de Adultos, Hospital Quito Sur del Instituto Ecuatoriano de Securidad Social, Quito, Ecuador.
Central University of Ecuador · ECHospital Vozandes · EC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 has a broad clinical spectrum, ranging from asymptomatic-mild form to severe phenotype. The severity of COVID-19 is a complex trait influenced by various genetic and environmental factors. Ethnic differences have been observed in relation to COVID-19 severity during the pandemic. It is currently unknown whether genetic variations may contribute to the increased risk of severity observed in Latin-American individuals The aim of this study is to investigate the potential correlation between gene variants at

Indexed as

2',5'-Oligoadenylate SynthetaseChemokine CCL2COVID-19Polymorphism, Single NucleotideSARS-CoV-2Severity of Illness IndexAdultAgedCase-Control StudiesEcuadorFemaleGene FrequencyGenetic Predisposition to DiseaseGenotypeHumansMale2',5'-Oligoadenylate SynthetaseCCL2 protein, humanChemokine CCL2OAS1 protein, humanassociation genetic studyCCL2COVID-19DPP9gene variantHardy-Weinberg equilibriumOAS1SNV

Identifiers

PMID38694517
PMCPMC11061356
OpenAlexW4394888181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.